Holen Sie sich die Stockscreener-App
4.71
2.61%
0.12
Handel nachbörslich:
4.67
-0.04
-0.85%
Schlusskurs vom Vortag:
$4.59
Offen:
$4.7
24-Stunden-Volumen:
7,506
Relative Volume:
0.66
Marktkapitalisierung:
$221.98M
Einnahmen:
$27,600
Nettoeinkommen (Verlust:
$-36.04M
KGV:
-5.9111
EPS:
-0.7968
Netto-Cashflow:
$-1.66M
1W Leistung:
+14.88%
1M Leistung:
+38.85%
6M Leistung:
+57.00%
1J Leistung:
-25.47%
1-Tages-Spanne:
$4.6944
$4.77
1-Wochen-Bereich:
$4.10
$4.83
52-Wochen-Spanne:
$2.76
$6.0096
Nanobiotix Adr Stock (NBTX) Company Profile
Vergleichen Sie NBTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
4.71 | 195.78M | 27,600 | -36.04M | -1.66M | -0.7968 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.232 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.34 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast - GlobeNewswire Inc.
Guggenheim cuts Nanobiotix stock target to $8, maintains buy - Investing.com
Nanobiotix SA ADR Reports 2024 Financial Results - TipRanks
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study - MSN
Mexico Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Latin America Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Middle East & Africa Chitosan Market Size & Outlook, 2030 - Grand View Research
The United States Chitosan Market Size & Outlook, 2030 - Grand View Research
China Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Japan Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study - TipRanks
Nanobiotix (NBTX) Stock Soared 107.9% on a Global Pharma Deal - AskTraders.com
NBTX News Today | Why did Nanobiotix stock go down today? - MarketBeat
Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
2.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):